# Enabling Microbiomics- Driven Personalized Nutrition

> **NCT06657001** · — · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 4001 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Irritable Bowel Syndrome (IBS)
- Celiac Disease
- Diarrhea
- Constipation
- Microbiome
- Crohn's Disease
- UC - Ulcerative Colitis
- Microscopic Colitis
- Functional Dyspepsia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06657001
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-03-28
- **Primary completion:** 2026-09
- **Final completion:** 2027-04
- **Target enrollment:** 4001 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06657001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06657001, "Enabling Microbiomics- Driven Personalized Nutrition". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06657001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*